Skip to main content
Advertisement
Neurology.org
Journals
Neurology
Clinical Practice
Genetics
Neuroimmunology & Neuroinflammation
Specialty Sites
Equity, Diversity and Inclusion
Innovations in Care Delivery
Without Borders
Collections
Topics A-Z
Residents & Fellows
Infographics
Patient Pages
Null Hypothesis
Translations
Podcast
CME
Article CME
Podcast CME
About
About the Journals
Contact Us
Editorial Board
Authors
Submit a Manuscript
Author Center
Search for this keyword
Advanced Search
Main menu
Neurology.org
Journals
Neurology
Clinical Practice
Genetics
Neuroimmunology & Neuroinflammation
Specialty Sites
Equity, Diversity and Inclusion
Innovations in Care Delivery
Without Borders
Collections
Topics A-Z
Residents & Fellows
Infographics
Patient Pages
Null Hypothesis
Translations
Podcast
CME
Article CME
Podcast CME
About
About the Journals
Contact Us
Editorial Board
Authors
Submit a Manuscript
Author Center
Home
Latest Articles
Current Issue
Past Issues
Residents & Fellows
User menu
Subscribe
My alerts
Log in
Search
Search for this keyword
Advanced search
The most widely read and highly cited peer-reviewed neurology journal
Subscribe
My alerts
Log in
Home
Latest Articles
Current Issue
Past Issues
Residents & Fellows
Share
May 26, 2009;
72
(21 Supplement 4)
The Scientific and Clinical Basis for the Treatment of Parkinson Disease (2009)
Share
Article
The scientific and clinical basis for the treatment of Parkinson disease (2009)
C. Warren Olanow
,
Matthew B. Stern
,
Kapil Sethi
Abstract
Full Text
Full Text (PDF)
Back to top
Previous
Next
Previous Issue
Next Issue
Table of Contents
Table of Contents (PDF)
Index by author
Subscribe to e-Alerts
RSS
Search for this keyword
Advertisement
Popular on
Neurology
Most Read
Most Cited
Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention
Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society
Practice guideline update summary: Acute treatment of migraine in children and adolescents
Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society
Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosis
Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
Quality improvement in neurology
Mild cognitive impairment quality measurement set
Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing
More...
Advertisement